Login / Signup

AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors.

Tadashi MatsushitaNobuaki SuzukiAzusa NagaoChiai NagaeHaruko Yamaguchi-SuitaYui KyogokuAkiko IokaKeiji Nogami
Published in: BMJ open (2022)
jRCTs041200037.
Keyphrases
  • stem cells
  • randomized controlled trial
  • study protocol
  • bone marrow
  • double blind